Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | LTA4H | P09960 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 2/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | PLK1 | P53350 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14134296 | 1.00 | MAPT (0.60) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL31000390 | 0.98 | MAPT (0.58) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL9155411 | 0.94 | MAPT (0.55) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| Dimethylamine SCHEMBL6784757 | 0.94 | MAPT (0.59) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| N-Propyl Bromide SCHEMBL9703833 | 0.94 | MAPT (0.55) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL916469 | 0.91 | LTA4H (0.57) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL7254241 | 0.89 | MAPT (0.51) | MAPTLTA4HKDM4EALDH1A1DRD4 | |
| SCHEMBL11578764 | 0.88 | LTA4H (0.55) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL31000372 | 0.88 | LTA4H (0.55) | MAPTLTA4HKDM4EALDH1A1CA12 | |
| SCHEMBL13845316 | 0.88 | APP (0.62) | MAPTLTA4HCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105872-A | Benzodiazepine compound and preparation method and application thereof | 徐州医科大学 | 2023-11-24 | — | — | CN | claimed |
| CN-104892598-A | A 1,10-fenanthrolin derivative, a preparing method thereof and applications of the derivative | UNIV NANJING INF SCI & TECH | 2015-09-09 | — | — | CN | claimed |
| CN-104163824-A | Gold-{2-(9-anthracene phenyl)dicyclohexylphosphine}-acetonitrile complex synthesis and application thereof | UNIV NANKAI | 2014-11-26 | — | — | CN | claimed |
| US-5380910-A | Dehalogeno coupling | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-10 | — | — | US | claimed |
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2025-11-25 | — | — | US | disclosed |
| CN-115210239-B | Aromatic compound, organic semiconductor layer, and organic thin film transistor | 东曹株式会社 | 2025-04-11 | — | — | CN | disclosed |
| CN-119564686-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119546609-A | Process for preparing 3, 6-disubstituted-imidazo [1,2-b ] pyridazine compounds | 葆元生物医药科技(杭州)有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119523983-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119424429-A | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| CN-115003665-B | DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) | 拜耳公司 | 2024-11-08 | — | — | CN | disclosed |
| WO-1997045397-A1 | ALKYLOXYAMINO SUBSTITUTED FLUORENONES AND THEIR USE AS PROTEIN KINASE C INHIBITORS | HOECHST MARION ROUSSEL, INC. (US) | 1997-12-04 | — | — | WO | disclosed |
| WO-1996040681-A1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ZENECA LIMITED (GB) | 1996-12-19 | — | — | WO | disclosed |
| EP-0571770-B1 | Method for producing an asymmetric biaryl derivative | IHARA CHEMICAL IND CO (JP) | 1996-07-10 | — | — | EP | disclosed |
| US-5380910-A | Dehalogeno coupling | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| CN-1084515-A | Phenyl sulfamoyl endothelium (endothelin) antagonistic | SQUIBB & SONS INC (US) | 1994-03-30 | — | — | CN | disclosed |
| EP-0571770-A1 | Method for producing an asymmetric biaryl derivative | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 1993-12-01 | — | — | EP | disclosed |
| CN-1021445-C | PROCESS FOR PREPARATION OF STEROIDS INCLUDING A SPIRO RING IN POSITION 17 | ROUSSEL UCLAF (FR) | 1993-06-30 | — | — | CN | disclosed |
| CN-87103193-A | Steroid compounds containing a spiro ring in position 17, process and intermediates for their production, their use as medicaments and pharmaceutical compositions containing them | — | 1988-01-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12478621-B2 | Substituted aminoquinolones as dgkalpha inhibitors for immune activation | DGKK, DGKG, DGKA | MAPT 4812/4885LTA4H 955/4885KDM4E 1315/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | MAPT 1809/4885LTA4H 4516/4885KDM4E 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.